All SEC Filings :: Syros Pharmaceuticals, Inc. (SYRS)

Filing Type:

Year:

Date	Form	Description	Pages
08/09/22	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2	63
08/09/22	424B3	Prospectus filed pursuant to Rule 424(b)(3)	713
08/08/22	EFFECT	Notice of Effectiveness	1
08/04/22	CORRESP	A correspondence can be sent as a document with another submission type or can be sent as a separate submission.	1
08/01/22	S-4/A	Registration of securities issued in business combination transactions Documents EX-5.1 EX-99.1 EX-99.2	16
07/20/22	UPLOAD	SEC-generated letter Documents TEXT-EXTRACT	1
07/18/22	DEL AM	Separately filed delaying amendment under Securities Act Rule 473 to delay effectiveness of a 1933 Act registration statement	1
07/18/22	S-4	Registration of securities issued in business combination transactions Documents EX-10.5 EX-23.1 EX-23.2 EX-99.3 EX-99.4 EX-FILING FEES	746
07/13/22	SC 13D	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities	8
07/13/22	SC 13D	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Documents EX-99.1 EX-99.2	95